Glaxo fined $3bn over US health fraud

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.
The UK’s largest pharmaceutical company was accused of bribing doctors in America to prescribe medicines for unapproved uses, with potentially dangerous side effects.